Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

Table 5 Estimated average treatment effects on the treated according to coronary intervention of the two groups (PPCI primary percutaneous coronary intervention, PIs: pharmacoinvasive strategy) adjusted for covariates

Outcome variable	Sample	Treated	Control	Difference	S.E	P value
30-day cardiovascular death or symptomatic heart failure	ATT	0.212	0.295	− 0.083	0.132	0.527
Successful reperfusion after PCI	ATT	0.824	0.922	− 0.099	0.065	0.127

Covariates include: age, sex, initial TIMI, total ischemia-to-reperfusion time, time to first contact, hypertension, diabetes mellitus, chronic kidney disease, cardiac arrest, and location)
ATT average treatment effects on the treated; S.E. definer, PCI percutaneous coronary intervention

ISSN: 1471-2261